OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Exploring the emerging trends in the synthesis and theranostic paradigms of cerium oxide nanoparticles (CeONPs): A comprehensive review
Sagnik Nag, Oishi Mitra, P. Sankarganesh, et al.
Materials Today Chemistry (2024) Vol. 35, pp. 101894-101894
Closed Access | Times Cited: 33

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 20

A multimodal therapy for infected diabetic wounds based on glucose-responsive nanocomposite-integrated microneedles
Qixin Zhou, Xiaodan Li, Nan Gao, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 4, pp. 1007-1021
Closed Access | Times Cited: 9

Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review
Sagnik Nag, Oishi Mitra, G. Tripathi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 12
Open Access | Times Cited: 14

Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention—a systematic review
Lucas Fornari Laurindo, Lívia Fornari Laurindo, Victória Dogani Rodrigues, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 398, Iss. 1, pp. 165-177
Closed Access | Times Cited: 4

The SGLT2 inhibitor remogliflozin induces vasodilation in the femoral artery of rabbits via activation of a Kv channel, the SERCA pump, and the cGMP signaling pathway
Minju Park, Wenwen Zhuang, Junsu Jeong, et al.
Toxicology and Applied Pharmacology (2025) Vol. 495, pp. 117228-117228
Closed Access

Prevalence of macro-vascular complications among type 2 diabetic adults aged 50 and over: results from Ardakan cohort study on aging (ACSA)
Mariye Jenabi Ghods, Alireza Amirabadizadeh, Ahmad Delbari, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access

Tolerance-enhancing microRNA: A new therapeutic target for plants
Sagnik Nag, Garima Tripathi, Anamika Mishra, et al.
Elsevier eBooks (2025), pp. 125-153
Closed Access

Antioxidants ameliorates glucose/glucose oxidase-induced myocardial damage through mitochondrial and MAPK Pathway
Santosh Kumar, Prachi Agrawal, Prachi Mendhey, et al.
Research Square (Research Square) (2025)
Closed Access

Lipotoxicity as a therapeutic target in the type 2 diabetic heart
Trang T. D. Luong, Seonbu Yang, Jaetaek Kim
Journal of Molecular and Cellular Cardiology (2025)
Closed Access

Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis
Zhaolun Zhang, Su‐Hsun Liu, Jiawen Xian, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access

Multireceptor Analysis for Evaluating the Antidiabetic Efficacy of Karanjin: A Computational Approach
Sagnik Nag, B. Stany, Shatakshi Mishra, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 2

Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024
Diana Carina Iovanovici, Bombonica Gabriela Dogaru, Carmen Delia Nistor-Cseppento, et al.
Balneo and PRM Research Journal (2024) Vol. 15, Iss. Vol.15, no. 2, pp. 683-683
Open Access | Times Cited: 2

Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review
Md. Faiyazuddin, Anggun Sophia, Sumel Ashique, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Risk Factors for Ankle Brachial Index and Carotid Artery Stenosis in Patients with Type 2 Diabetes
Vesna Đermanović Dobrota, Neva Brkljačić, Angelika Tičinović Ivančić, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 59-59
Open Access | Times Cited: 1

Insights into the Cardioprotective Effects of Pyridoxine Treatment in Diabetic Rats: A Study on Cardiac Oxidative Stress, Cardiometabolic Status, and Cardiovascular Biomarkers
Slavica Mutavdžin, Kristina Gopčević, Sanja Stanković, et al.
Diagnostics (2024) Vol. 14, Iss. 14, pp. 1507-1507
Open Access | Times Cited: 1

Melatonin alleviates high glucose-induced cardiomyocyte injury through suppressing mitochondrial FUNDC1-DRP1 axis
Junyi Zheng, Lili Zhao, Yingying Zhang, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access | Times Cited: 1

Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders
Antonietta Fazio, Camilla Evangelisti, Alessandra Cappellini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13096-13096
Open Access | Times Cited: 2

Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88
Qianhui Zhang, Weiwei Zhu, Shuaijie Lou, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110863-110863
Closed Access | Times Cited: 2

Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
Sagnik Nag, Oishi Mitra, Bhanu Maturi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100927-100927
Open Access

Mechanistic Insights and Therapeutic Potential of Astilbin and Apigenin in Diabetic cardiomyopathy
Sachin Dhiman, Sanchit Dhankhar, Anjali Garg, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39996-e39996
Open Access

Predictive markers of early endothelial dysregulation in type-1 diabetes: a meta-analysis
Ranmali Ranasinghe, Michael L. Mathai, Mohammed Abdullah Alshawsh, et al.
Acta Diabetologica (2024)
Closed Access

Myocardial Fibrosis in Diabetic Cardiomyopathy: Mechanisms, Implications, and Therapeutic Perspectives
C. Schmidt, H Müller
Current Problems in Cardiology (2024), pp. 102976-102976
Closed Access

Page 1 - Next Page

Scroll to top